Detalhe da pesquisa
1.
Treatment Outcomes of Childhood Tuberculous Meningitis in a Real-World Retrospective Cohort, Bandung, Indonesia.
Emerg Infect Dis
; 28(3): 660-671, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35202524
2.
Metallic hemiarthroplasty or arthrodesis of the first metatarsophalangeal joint as treatment for hallux rigidus: A systematic review and meta-analysis.
Foot Ankle Surg
; 28(2): 139-152, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33812802
3.
Gait analysis of foot compensation in symptomatic Hallux Rigidus patients.
Foot Ankle Surg
; 28(8): 1272-1278, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35717495
4.
Inter-individual variability in atrasentan exposure partly explains variability in kidney protection and fluid retention responses: A post hoc analysis of the SONAR trial.
Diabetes Obes Metab
; 23(2): 561-568, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33184931
5.
Safety, pharmacokinetics and pharmacodynamics of HTL0009936, a selective muscarinic M1 -acetylcholine receptor agonist: A randomized cross-over trial.
Br J Clin Pharmacol
; 87(11): 4439-4449, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33891333
6.
The power of modelling pulsatile profiles.
J Pharmacokinet Pharmacodyn
; 48(3): 439-444, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33660229
7.
Pharmacokinetics of fosfomycin in patients with prophylactic treatment for recurrent Escherichia coli urinary tract infection.
J Antimicrob Chemother
; 75(11): 3278-3285, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32712666
8.
Exposure-response relationships for the sodium-glucose co-transporter-2 inhibitor dapagliflozin with regard to renal risk markers.
Diabetes Obes Metab
; 22(6): 916-921, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31984620
9.
Exposure and response analysis of aleglitazar on cardiovascular risk markers and safety outcomes: An analysis of the AleCardio trial.
Diabetes Obes Metab
; 22(1): 30-38, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31468659
10.
Exposure-response relationships of dapagliflozin on cardiorenal risk markers and adverse events: A pooled analysis of 13 phase II/III trials.
Br J Clin Pharmacol
; 86(11): 2192-2203, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32311110
11.
Model informed quantification of the feed-forward stimulation of growth hormone by growth hormone-releasing hormone.
Br J Clin Pharmacol
; 86(8): 1575-1584, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32087619
12.
The effect of food and formulation on the population pharmacokinetics of cholesteryl ester transferase protein inhibitor DRL-17822 in healthy male volunteers.
Br J Clin Pharmacol
; 86(10): 2095-2101, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32250455
13.
Quantification of the endogenous growth hormone and prolactin lowering effects of a somatostatin-dopamine chimera using population PK/PD modeling.
J Pharmacokinet Pharmacodyn
; 47(3): 229-239, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32248329
14.
Association between individual cholesterol and proteinuria response and exposure to atorvastatin or rosuvastatin.
Diabetes Obes Metab
; 21(12): 2635-2642, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31414562
15.
The Pharmacodynamic Effects of a Dopamine-Somatostatin Chimera Agonist on the Cardiovascular System.
J Cardiovasc Pharmacol
; 74(2): 128-136, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31306369
16.
Sex-based differences in nuclear medicine imaging and therapy.
Eur J Nucl Med Mol Imaging
; 50(4): 971-974, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36633615
17.
Determining the optimal dose of atrasentan by evaluating the exposure-response relationships of albuminuria and bodyweight.
Diabetes Obes Metab
; 20(8): 2019-2022, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29603851
18.
How are growth hormone and insulin-like growth factor-1 reported as markers for drug effectiveness in clinical acromegaly research? A comprehensive methodologic review.
Pituitary
; 21(3): 310-322, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29605877
19.
The use of a battery of pain models to detect analgesic properties of compounds: a two-part four-way crossover study.
Br J Clin Pharmacol
; 83(5): 976-990, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27862179
20.
An anti-nicotinic cognitive challenge model using mecamylamine in comparison with the anti-muscarinic cognitive challenge using scopolamine.
Br J Clin Pharmacol
; 83(8): 1676-1687, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28217868